Inmune Bio, Inc. (INMB)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $110k
- Jul 12 · Routine
- Form 4 sales
- 19
- On record
- Form 144 notices
- 1
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Jul 12, 2023Routine
Schroeder Timothy j, Director, sold 10.8% of their holdings
$110k10,000 shares at $11.01
- Jul 12, 2023Notice
CTI Holdings, Inc, Director, filed a notice to sell 60,000 shares
$960k60,000 shares
- Nov 3, 2021Plan not stated
Lowdell Mark William, Chief Scientific Officer, sold under 0.1% of their holdings
$14k701 shares at $20.00
- Nov 3, 2021Plan not stated
Moss David J, CFO, Treasurer & Secretary, sold 0.1% of their holdings
$21k1,025 shares at $20.00
- Nov 3, 2021Plan not stated
Tesi Raymond Joseph, President and CEO, sold 0.2% of their holdings
$73k3,626 shares at $20.00
- Oct 27, 2021Plan not stated
Tesi Raymond Joseph, President and CEO, sold 0.4% of their holdings
$130k6,517 shares at $20.00
- Oct 27, 2021Plan not stated
Lowdell Mark William, Chief Scientific Officer, sold 0.2% of their holdings
$47k2,357 shares at $20.00
- Oct 27, 2021Plan not stated
Moss David J, CFO, Treasurer & Secretary, sold 0.2% of their holdings
$42k2,079 shares at $20.00
- Oct 25, 2021Plan not stated
Moss David J, CFO, Treasurer & Secretary, sold 0.1% of their holdings
$23k1,155 shares at $20.00
- Oct 22, 2021Plan not stated
Tesi Raymond Joseph, President and CEO, sold 1.5% of their holdings
$472k23,616 shares at $20.00
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 23, 2026 | INMB | Clark Ronnie Duane | Director | AwardedStock Options | 100,000 | 100,000 | SEC | ||
| Sep 15, 2026 | Sep 17, 2026 | INMB | Sapirstein James | Director | AwardedStock Options | 100,000 | 100,000 | SEC | ||
| Jul 2, 2026 | Jul 7, 2026 | INMB | Juda Scott | Director | Exercised or settledCommon Stock Purchase Warrant | 14,801 | $0.13 | $2k | 14,802 | SEC |
| Jul 2, 2026 | Jul 7, 2026 | INMB | Juda Scott | Director | Exercised options | 14,801 | $1.40 | $21k | 86,404 | SEC |
| Jul 2, 2026 | Jul 7, 2026 | INMB | Lowdell Mark William | Chief Scientific Officer | Exercised or settledCommon Stock Purchase Warrant | 7,211 | $0.13 | $937 | 7,212 | SEC |
| Jul 2, 2026 | Jul 7, 2026 | INMB | Lowdell Mark William | Chief Scientific Officer | Exercised options | 7,211 | $1.40 | $10k | 1.5M | SEC |
| Jul 2, 2026 | Jul 7, 2026 | INMB | Moss David J | Chief Executive Officer | Exercised or settledCommon Stock Purchase Warrant | 9,014 | $0.13 | $1k | 9,014 | SEC |
| Jul 2, 2026 | Jul 7, 2026 | INMB | Moss David J | Chief Executive Officer | Exercised options | 9,014 | $1.40 | $13k | 1.3M | SEC |
| Dec 1, 2025 | Dec 2, 2025 | INMB | Moss David J | Chief Executive Officer | AwardedOption (right to buy) | 750,000 | 750,000 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | INMB | Lowdell Mark William | Chief Scientific Officer | AwardedOption (right to buy) | 600,000 | 600,000 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | INMB | Ellspermann Cory Randall | CFO | AwardedOption (right to buy) | 300,000 | 300,000 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | INMB | Schroeder Timothy j | Director | AwardedOption (right to buy) | 150,000 | 150,000 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | INMB | Juda Scott | Director | AwardedOption (right to buy) | 150,000 | 150,000 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | INMB | Ganjei James Kelly | Director | AwardedOption (right to buy) | 150,000 | 150,000 | SEC | ||
| Dec 1, 2025 | Dec 2, 2025 | INMB | Allen Marcia | Director | AwardedOption (right to buy) | 150,000 | 150,000 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Schroeder Timothy j | Director | Returned to the companyStock Option (right to buy) | 366,000 | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Schroeder Timothy j | Director | AwardedStock Option (right to buy) | 366,000 | 12,500 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Moss David J | Chief Executive Officer | Returned to the companyStock Option (right to buy) | 1.5M | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Moss David J | Chief Executive Officer | AwardedStock Option (right to buy) | 1.5M | 160,000 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Lowdell Mark William | Chief Scientific Officer | Returned to the companyStock Option (right to buy) | 924,000 | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Lowdell Mark William | Chief Scientific Officer | AwardedStock Option (right to buy) | 924,000 | 100,000 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Juda Scott | Director | Returned to the companyStock Option (right to buy) | 366,000 | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Juda Scott | Director | AwardedStock Option (right to buy) | 366,000 | 12,500 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Ganjei James Kelly | Director | Returned to the companyStock Option (right to buy) | 366,000 | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Ganjei James Kelly | Director | AwardedStock Option (right to buy) | 366,000 | 12,500 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Ellspermann Cory Randall | Interim CFO | Returned to the companyStock Option (right to buy) | 245,000 | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Ellspermann Cory Randall | Interim CFO | AwardedStock Option (right to buy) | 245,000 | 30,000 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Allen Marcia | Director | Returned to the companyStock Option (right to buy) | 258,000 | 0 | SEC | ||
| Nov 18, 2025 | Nov 18, 2025 | INMB | Allen Marcia | Director | AwardedStock Option (right to buy) | 258,000 | 12,500 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Allen Marcia | Director | AwardedOption (right to buy) | 32,500 | 32,500 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Tesi Raymond Joseph | President and CEO | AwardedOption (right to buy) | 226,000 | 226,000 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Moss David J | Chief Financial Officer | AwardedOption (right to buy) | 223,000 | 223,000 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Lowdell Mark William | Chief Scientific Officer | AwardedOption (right to buy) | 140,000 | 140,000 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Juda Scott | Director | AwardedOption (right to buy) | 32,500 | 32,500 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Schroeder Timothy j | Director | AwardedOption (right to buy) | 32,500 | 32,500 | SEC | ||
| Dec 5, 2024 | Dec 9, 2024 | INMB | Ganjei James Kelly | Director | AwardedOption (right to buy) | 32,500 | 32,500 | SEC | ||
| Sep 30, 2024 | Sep 30, 2024 | INMB | Moss David J | Chief Financial Officer | Bought | 10,000 | $5.29 | $53k | 1.3M | SEC |
| Sep 12, 2024 | Sep 16, 2024 | INMB | Tesi Raymond Joseph | President and CEO | BoughtCommon Stock Warrants (right to buy) | 15,380 | $0.13 | $2k | 15,380 | SEC |
| Sep 12, 2024 | Sep 16, 2024 | INMB | Tesi Raymond Joseph | President and CEO | Bought | 15,380 | $6.38 | $98k | 1.6M | SEC |
| Sep 12, 2024 | Sep 16, 2024 | INMB | Moss David J | Chief Financial Officer | BoughtCommon Stock Warrants (right to buy) | 7,690 | $0.13 | $1000 | 7,690 | SEC |
| Sep 12, 2024 | Sep 16, 2024 | INMB | Moss David J | Chief Financial Officer | Bought | 7,690 | $6.38 | $49k | 1.3M | SEC |
| Jun 25, 2024 | Jun 26, 2024 | INMB | Juda Scott | Director | Bought | 5,000 | $7.27 | $36k | 71,603 | SEC |
| Jun 10, 2024 | Jun 12, 2024 | INMB | Tesi Raymond Joseph | President and CEO | AwardedOption (right to buy) | 37,882 | 37,882 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Tesi Raymond Joseph | President and CEO | AwardedOption (right to buy) | 160,000 | 160,000 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Schroeder Timothy j | Director | AwardedOption (right to buy) | 12,500 | 12,500 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Moss David J | Chief Financial Officer | AwardedOption (right to buy) | 160,000 | 160,000 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Lowdell Mark William | Chief Scientific Officer | AwardedOption (right to buy) | 100,000 | 100,000 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Juda Scott | Director | AwardedOption (right to buy) | 12,500 | 12,500 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Ganjei James Kelly | Director | AwardedOption (right to buy) | 12,500 | 12,500 | SEC | ||
| May 14, 2024 | May 16, 2024 | INMB | Baracchini Edgardo Jr | Director | AwardedOption (right to buy) | 12,500 | 12,500 | SEC |
Sales, notices and lockups (20)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2023 | Jul 14, 2023 | Schroeder Timothy j | INMB | Director | Form 4 sale | 10,000 | $110k | 10.8% | Routine | SEC |
| Jul 12, 2023 | Jul 12, 2023 | CTI Holdings, Inc | INMB | Director | Form 144 notice | 60,000 | $960k | Notice | SEC | |
| Nov 3, 2021 | Nov 4, 2021 | Lowdell Mark William | INMB | Chief Scientific Officer | Form 4 sale | 701 | $14k | 0.0% | Plan not stated | SEC |
| Nov 3, 2021 | Nov 4, 2021 | Moss David J | INMB | CFO, Treasurer & Secretary | Form 4 sale | 1,025 | $21k | 0.1% | Plan not stated | SEC |
| Nov 3, 2021 | Nov 4, 2021 | Tesi Raymond Joseph | INMB | President and CEO | Form 4 sale | 3,626 | $73k | 0.2% | Plan not stated | SEC |
| Oct 27, 2021 | Oct 29, 2021 | Tesi Raymond Joseph | INMB | President and CEO | Form 4 sale | 6,517 | $130k | 0.4% | Plan not stated | SEC |
| Oct 27, 2021 | Oct 29, 2021 | Lowdell Mark William | INMB | Chief Scientific Officer | Form 4 sale | 2,357 | $47k | 0.2% | Plan not stated | SEC |
| Oct 27, 2021 | Oct 29, 2021 | Moss David J | INMB | CFO, Treasurer & Secretary | Form 4 sale | 2,079 | $42k | 0.2% | Plan not stated | SEC |
| Oct 25, 2021 | Oct 26, 2021 | Moss David J | INMB | CFO, Treasurer & Secretary | Form 4 sale | 1,155 | $23k | 0.1% | Plan not stated | SEC |
| Oct 22, 2021 | Oct 26, 2021 | Tesi Raymond Joseph | INMB | President and CEO | Form 4 sale | 23,616 | $472k | 1.5% | Plan not stated | SEC |
| Oct 22, 2021 | Oct 26, 2021 | Lowdell Mark William | INMB | Chief Scientific Officer | Form 4 sale | 400 | $8k | 0.0% | Plan not stated | SEC |
| Jul 13, 2021 | Jul 14, 2021 | Schroeder Timothy j | INMB | Director | Form 4 sale | 14,480 | $400k | 13.6% | Plan not stated | SEC |
| Jul 9, 2021 | Jul 12, 2021 | Schroeder Timothy j | INMB | Director | Form 4 sale | 30,000 | $696k | 22.0% | Unusual | SEC |
| Jul 8, 2021 | Jul 9, 2021 | Lowdell Mark William | INMB | Chief Scientific Officer | Form 4 sale | 30,000 | $605k | 2.0% | Plan not stated | SEC |
| Jul 8, 2021 | Jul 9, 2021 | Moss David J | INMB | CFO, Treasurer & Secretary | Form 4 sale | 25,000 | $502k | 2.0% | Plan not stated | SEC |
| Jul 8, 2021 | Jul 9, 2021 | Tesi Raymond Joseph | INMB | President and CEO | Form 4 sale | 30,000 | $602k | 1.9% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 15, 2021 | Schroeder Timothy j | INMB | Director | Form 4 sale | 10,000 | $190k | 6.8% | Plan not stated | SEC |
| Jun 10, 2021 | Jun 14, 2021 | Schroeder Timothy j | INMB | Director | Form 4 sale | 10,000 | $170k | 6.4% | Plan not stated | SEC |
| Mar 31, 2021 | Apr 1, 2021 | Schroeder Timothy j | INMB | Director | Form 4 sale | 10,000 | $120k | 6.0% | Plan not stated | SEC |
| Jan 27, 2020 | Jan 29, 2020 | Powers Linda F | INMB | 10% owner | Form 4 sale | 220,000 | $1M | 51.2% | Unusual | SEC |